Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology Indian Medical PG Practice Questions and MCQs

Question 611: Which of the following statements is not true regarding the mechanism of action of benzodiazepines?

A. Acts on the midbrain, ascending reticular formation, and limbic system.
B. Exerts effects through the GABA A receptors.
C. Increases the conductance of Cl- channels.
D. Has GABA mimetic action. (Correct Answer)

Explanation: ### Explanation The mechanism of action of Benzodiazepines (BZDs) is a high-yield topic for NEET-PG. To understand why **Option D** is the correct answer (the false statement), we must distinguish between **GABA-facilitatory** and **GABA-mimetic** actions. **1. Why Option D is the correct answer (False statement):** Benzodiazepines are **GABA-facilitatory**, not GABA-mimetic. They require the presence of endogenous GABA to function. They bind to an allosteric site on the GABA-A receptor and increase the **frequency** of chloride channel opening. In contrast, **Barbiturates** at high doses can act as GABA-mimetics (directly opening the channel even in the absence of GABA), which is why they have a lower safety margin and can cause profound CNS depression compared to BZDs. **2. Analysis of Incorrect Options (True statements):** * **Option A:** BZDs act on multiple levels of the neuraxis. Their sedative-hypnotic effects are mediated via the **ascending reticular formation**, while their anxiolytic effects are primarily due to action on the **limbic system**. * **Option B:** BZDs bind specifically to the alpha-gamma interface of the **GABA-A receptor** (a pentameric ligand-gated chloride channel). * **Option C:** By increasing the frequency of channel opening, BZDs increase **Chloride (Cl-) conductance**, leading to neuronal hyperpolarization and inhibition. ### High-Yield Clinical Pearls for NEET-PG: * **BZD Antagonist:** **Flumazenil** (competitive antagonist at the BZD site). * **Receptor Subtypes:** $\alpha_1$ subunits mediate sedation/hypnosis; $\alpha_2$ and $\alpha_3$ subunits mediate anxiolytic and muscle relaxant effects. * **Safety:** BZDs exhibit a "ceiling effect" because they depend on endogenous GABA, making them safer than barbiturates in overdose. * **Mnemonic:** Benzodiazepines increase **Fr**equency (**Fr**enzodiazepines); Barbiturates increase **Du**ration (**Barbi-durat-es**).

Question 612: Which sedative agent facilitates GABAergic action but lacks anticonvulsant and muscle relaxant properties, and does not affect sleep?

A. Diazepam
B. Zolpidem (Correct Answer)
C. Phenobarbitone
D. Buspirone

Explanation: ### Explanation **Correct Answer: B. Zolpidem** **Mechanism and Rationale:** Zolpidem is a non-benzodiazepine sedative-hypnotic (Z-drug). While it facilitates GABAergic action like benzodiazepines, it is highly selective for the **$\alpha_1$ subunit** of the $GABA_A$ receptor [1]. * The **$\alpha_1$ subunit** mediates sedation and amnesia. * The **$\alpha_2, \alpha_3,$ and $\alpha_5$ subunits** are responsible for anxiolytic, muscle relaxant, and anticonvulsant effects. Because Zolpidem lacks significant affinity for these other subunits, it provides pure sedation without the muscle relaxant or anticonvulsant properties associated with traditional benzodiazepines [1]. Furthermore, it has minimal impact on sleep architecture (it does not significantly suppress REM or N3 sleep stages), making it ideal for treating insomnia [2]. **Analysis of Incorrect Options:** * **A. Diazepam:** A classic benzodiazepine that binds non-selectively to $\alpha_1, \alpha_2, \alpha_3,$ and $\alpha_5$ subunits. Consequently, it possesses potent anticonvulsant, muscle relaxant, and anxiolytic properties. * **C. Phenobarbitone:** A barbiturate that increases the *duration* of GABA channel opening. It is a powerful anticonvulsant and significantly alters sleep architecture (decreases REM sleep) [2]. * **D. Buspirone:** An anxiolytic that acts as a **5-$HT_{1A}$ partial agonist**. It does not facilitate GABAergic action and lacks sedative, anticonvulsant, or muscle relaxant properties. **High-Yield NEET-PG Pearls:** * **Z-drugs (Zolpidem, Zaleplon, Eszopiclone):** Preferred for insomnia due to low potential for tolerance, dependence, and "hangover" effects. * **Antidote:** Flumazenil reverses the effects of both Benzodiazepines and Z-drugs. * **Zaleplon:** Has the shortest half-life among Z-drugs, useful for sleep-onset insomnia. * **Eszopiclone:** Often used for long-term management of insomnia.

Question 613: An addict presents with increased sweating, lacrimation, diarrhea, yawning, and rhinorrhea. These symptoms may occur due to withdrawal of which substance?

A. Heroin (Correct Answer)
B. Cocaine
C. Cannabis
D. Alcohol

Explanation: ### Explanation The clinical presentation described—**lacrimation, rhinorrhea, yawning, sweating, and diarrhea**—is the classic "wet" withdrawal syndrome characteristic of **Opioids (Heroin)**. **1. Why Heroin is Correct:** Heroin is a potent opioid agonist. Chronic use leads to the downregulation of endogenous opioid receptors and suppression of the locus coeruleus (the brain's norepinephrine center). When the drug is withdrawn, there is a massive "rebound" of sympathetic and parasympathetic activity. * **Key Symptoms:** Mydriasis (dilated pupils), piloerection (goosebumps—hence "cold turkey"), yawning, and excessive secretions (flu-like symptoms: rhinorrhea, lacrimation, and diarrhea). While distressing, opioid withdrawal is generally not life-threatening. **2. Why the Other Options are Incorrect:** * **Cocaine:** Withdrawal typically presents as a "crash" characterized by profound depression, hypersomnia (excessive sleep), hyperphagia (increased appetite), and intense craving, but lacks the "wet" secretory symptoms. * **Cannabis:** Withdrawal is mild and includes irritability, insomnia, and decreased appetite. * **Alcohol:** Withdrawal is potentially life-threatening. It presents with tremors, tachycardia, seizures, and **Delirium Tremens** (confusion, hallucinations). While sweating occurs, it lacks the specific triad of yawning, lacrimation, and rhinorrhea. **3. NEET-PG High-Yield Pearls:** * **Treatment of Choice (Withdrawal):** Methadone or Buprenorphine (substitution therapy). * **Symptomatic Relief:** **Clonidine** (α2 agonist) is used to reduce the autonomic overactivity (sweating, diarrhea) by inhibiting norepinephrine release. * **The "Gooseflesh" Sign:** Piloerection is a pathognomonic sign of severe opioid withdrawal. * **Mnemonic:** Remember **"SLUDGE"** (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) for opioid withdrawal, similar to cholinergic excess.

Question 614: What is the primary difference between opioids and opiates?

A. Opioids are more powerful in action.
B. Opioids are more long-acting.
C. Opioids are synthetic derivatives. (Correct Answer)
D. Opioids are derived directly from opium.

Explanation: The distinction between **opiates** and **opioids** is a fundamental concept in neuropharmacology, often tested in competitive exams like NEET-PG to assess a student's grasp of pharmacological terminology and drug origins. ### **Explanation of the Correct Answer** The correct answer is **C**. The primary difference lies in their **origin**: * **Opiates** are natural alkaloids derived directly from the resin of the opium poppy (*Papaver somniferum*). Examples include Morphine, Codeine, and Thebaine. * **Opioids** is a broader, umbrella term that includes all substances (natural, semi-synthetic, and synthetic) that bind to opioid receptors ($\mu, \kappa, \delta$) and are antagonized by Naloxone. In the context of this question, "Opioids" refers to the **synthetic and semi-synthetic derivatives** (e.g., Fentanyl, Methadone, Tramadol) created to mimic or enhance the effects of natural opiates. ### **Analysis of Incorrect Options** * **Option A:** Potency is not the defining difference. While some synthetic opioids (like Fentanyl) are significantly more powerful than morphine, others (like Propoxyphene) are weaker. * **Option B:** Duration of action varies by specific drug, not by category. For example, Remifentanil (synthetic) is ultra-short-acting, while Morphine (natural) lasts longer. * **Option D:** This describes **Opiates**, not Opioids. ### **NEET-PG High-Yield Clinical Pearls** * **Endogenous Opioids:** Remember the three families: Endorphins (from POMC), Enkephalins (Pro-enkephalin), and Dynorphins (Pro-dynorphin). * **Receptor Specificity:** $\mu$ (Mu) receptors are primarily responsible for supraspinal analgesia, respiratory depression, and physical dependence. * **Gold Standard:** Morphine remains the prototype against which all other opioid analgesics are compared. * **Antidote:** Naloxone is the drug of choice for acute opioid toxicity (competitive antagonist at all opioid receptors).

Question 615: A young man with a known history of heroin addiction is brought to the emergency department in an unconscious state. On examination, the patient presents with decreased bowel sounds, depressed respiration, and pinpoint pupils. What is the treatment of choice for this patient?

A. Oral naltrexone
B. Intravenous naloxone (Correct Answer)
C. Oral diazepam
D. Oral buprenorphine

Explanation: ### Explanation **Correct Answer: B. Intravenous naloxone** **Mechanism and Rationale:** The patient presents with the classic **"Opioid Overdose Triad"**: Coma (unconscious), Respiratory Depression, and Miosis (pinpoint pupils). Decreased bowel sounds further confirm opioid-induced slowing of gastrointestinal motility. In an acute emergency, the priority is to reverse respiratory depression. **Naloxone** is a competitive opioid antagonist with a high affinity for $\mu$-receptors. It is the treatment of choice because it acts rapidly (within 1–2 minutes when given IV) to displace the heroin from the receptors and restore spontaneous breathing. **Why other options are incorrect:** * **A. Oral naltrexone:** While naltrexone is an opioid antagonist, it has a long duration of action and is used for **relapse prevention** (maintenance therapy) in detoxified patients. It is not used in emergencies due to its slow onset and oral administration. * **C. Oral diazepam:** Diazepam is a benzodiazepine and a CNS depressant. Administering it to a patient with respiratory depression would worsen the condition and potentially be fatal. * **D. Oral buprenorphine:** This is a partial $\mu$-agonist used for opioid substitution therapy. In an acute overdose, adding a partial agonist will not provide the rapid reversal required and may even complicate the clinical picture. **High-Yield Clinical Pearls for NEET-PG:** * **Short Half-life:** Naloxone has a shorter half-life (approx. 30–60 mins) than most opioids (like heroin or methadone). Therefore, **repeated dosing** or an IV infusion may be necessary to prevent the patient from slipping back into a coma once the naloxone wears off. * **Diagnostic Use:** Naloxone is often used as a diagnostic tool in "coma of unknown origin." * **Withdrawal:** Rapid administration in an addict can precipitate **acute withdrawal syndrome** (agitation, vomiting, lacrimation, rhinorrhea).

Question 616: Which drug is used to control status epilepticus?

A. Diazepam (Correct Answer)
B. Sodium nitroprusside
C. Glyceryl trinitrite
D. Phenobarbital

Explanation: **Explanation:** **Status Epilepticus (SE)** is a medical emergency defined as a continuous seizure lasting more than 5 minutes or recurrent seizures without recovery of consciousness between episodes. **Why Diazepam is correct:** Benzodiazepines (BZDs) are the first-line agents for terminating acute seizures. **Diazepam** (or Lorazepam) works by enhancing GABA-mediated chloride channel opening, leading to hyperpolarization and rapid suppression of epileptiform activity. While Lorazepam is often preferred in hospital settings due to its longer duration of action in the brain, Diazepam remains a classic correct answer for the initial control of SE, especially in pre-hospital or emergency scenarios. **Why the other options are incorrect:** * **Sodium Nitroprusside (B):** This is a potent vasodilator used in hypertensive emergencies to lower blood pressure. It has no anticonvulsant properties. * **Glyceryl Trinitrate (C):** Also known as Nitroglycerin, it is used primarily for angina pectoris and acute heart failure. It does not cross the blood-brain barrier effectively to stop seizures. * **Phenobarbital (D):** While Phenobarbital is an effective anticonvulsant, it is typically considered a second or third-line agent (used if BZDs and Phenytoin fail) due to its slow onset and risk of respiratory depression. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Initial):** IV Lorazepam is preferred over Diazepam because it is less lipid-soluble and stays in the brain longer. * **Drug of Choice (Maintenance):** IV Fosphenytoin or Phenytoin is used to prevent the recurrence of seizures after the initial BZD dose. * **Refractory SE:** If seizures continue despite BZDs and Phenytoin, IV Midazolam, Propofol, or Thiopental (general anesthesia) are used. * **Route:** If IV access is unavailable, **Rectal Diazepam** or **Intranasal/Buccal Midazolam** are vital alternatives in pediatric or pre-hospital settings.

Question 617: A patient on Phenytoin therapy develops depression, for which he was prescribed tricyclic antidepressants. He now complains of lassitude and his Hb reading is 8 gm/dl. What is the next step in the management of this patient?

A. Chest X-ray
B. Estimate MCV (Correct Answer)
C. Estimate GGT
D. None of the above

Explanation: ### Explanation **1. Why "Estimate MCV" is the correct answer:** The patient is presenting with symptoms of anemia (lassitude, Hb 8 gm/dl) while on long-term **Phenytoin** therapy. Phenytoin is a well-known inducer of **folate deficiency**, which leads to **Megaloblastic Anemia**. The mechanism involves Phenytoin interfering with intestinal folate absorption and increasing its metabolism. In megaloblastic anemia, the Mean Corpuscular Volume (MCV) is elevated (>100 fL). Therefore, estimating the MCV is the most appropriate next step to confirm the presence of macrocytosis before initiating folic acid supplementation. *Note:* Tricyclic antidepressants (TCAs) are mentioned as a distractor, though they can occasionally lower the seizure threshold, they are not the primary cause of the hematological findings here. **2. Why other options are incorrect:** * **Chest X-ray:** While Phenytoin can rarely cause interstitial lung disease, it does not explain the low hemoglobin and lassitude. * **Estimate GGT:** Gamma-glutamyl transferase (GGT) is a marker of enzyme induction or liver pathology. While Phenytoin is a potent hepatic enzyme inducer and can raise GGT levels, this test does not help diagnose the cause of the patient's anemia. **3. Clinical Pearls for NEET-PG:** * **Phenytoin Side Effects (Mnemonic: HOT MALAI):** **H**irsutism, **O**steomalacia, **T**eratogenicity (Fetal Hydantoin Syndrome), **M**egaloblastic anemia, **A**taxia, **L**ymphadenopathy, **A**rrythmias (on rapid IV), **I**nsulin inhibition (Hyperglycemia), and **Gingival Hyperplasia**. * **Folate Supplementation:** Giving folic acid to a patient on Phenytoin can actually *decrease* the serum levels of Phenytoin (by increasing its metabolism), potentially leading to breakthrough seizures. * **Zero-Order Kinetics:** Phenytoin follows saturation kinetics; small dose increases can lead to toxic levels.

Question 618: All of the following decrease skeletal muscle tone by CNS effects, except:

A. D-tubocurarin (Correct Answer)
B. Diazepam
C. Baclofen
D. Mephenesin

Explanation: Skeletal muscle relaxants are broadly classified into two categories based on their site of action: **Centrally acting muscle relaxants** and **Peripherally acting muscle relaxants**. ### **Explanation of the Correct Answer** **A. D-tubocurarine:** This is a **peripherally acting** neuromuscular blocker. It acts at the **Neuromuscular Junction (NMJ)** by competitively antagonizing nicotinic acetylcholine receptors ($N_m$) on the motor endplate. It does not cross the blood-brain barrier and, therefore, has **no CNS effects**. This makes it the "except" in the list. ### **Explanation of Incorrect Options** * **B. Diazepam:** A Benzodiazepine that acts centrally by enhancing **GABA-A** mediated presynaptic inhibition in the spinal cord. It is used for both muscle spasms and spasticity. * **C. Baclofen:** A centrally acting agent that is a selective **GABA-B agonist**. It acts primarily at the spinal level to reduce excitatory neurotransmitter release, effectively reducing spasticity in conditions like Multiple Sclerosis. * **D. Mephenesin:** The prototype of centrally acting muscle relaxants. It acts on the **internuncial neurons** of the spinal cord to reduce skeletal muscle tone without affecting consciousness. ### **High-Yield Clinical Pearls for NEET-PG** * **Dantrolene:** The only peripherally acting muscle relaxant that acts **directly on the muscle** (by inhibiting Calcium release from the Sarcoplasmic Reticulum via RyR1 receptors). It is the drug of choice for **Malignant Hyperthermia**. * **Tizanidine:** A centrally acting muscle relaxant that works as an **$\alpha_2$ adrenergic agonist** (similar to clonidine but with less hypotensive effect). * **Site Summary:** * CNS: Diazepam, Baclofen, Tizanidine. * NMJ: D-tubocurarine, Succinylcholine. * Muscle: Dantrolene.

Question 619: Which benzodiazepine does not have significant anticonvulsant properties?

A. Nitrazepam
B. Diazepam
C. Clonazepam
D. Temazepam (Correct Answer)

Explanation: **Explanation:** Benzodiazepines (BZDs) act by potentiating GABA-mediated inhibitory neurotransmission. While most BZDs share common properties (anxiolytic, sedative-hypnotic, muscle relaxant, and anticonvulsant), their clinical utility is determined by their specific receptor affinity and pharmacokinetic profile. **Why Temazepam is the correct answer:** Temazepam is a **short-to-intermediate acting BZD** primarily used as a **hypnotic** for the treatment of insomnia. It lacks significant anticonvulsant or muscle relaxant properties at standard therapeutic doses. Its pharmacological profile is optimized for inducing and maintaining sleep without the prolonged CNS depression required for seizure suppression. **Analysis of Incorrect Options:** * **Nitrazepam:** Primarily used as a hypnotic, but it possesses potent anticonvulsant properties and is clinically used in the management of infantile spasms (West Syndrome) and certain myoclonic seizures. * **Diazepam:** A prototype long-acting BZD. It is a first-line agent for terminating acute seizures and **Status Epilepticus** due to its high lipid solubility and rapid brain entry. * **Clonazepam:** A highly potent BZD specifically used as a long-term **antiepileptic drug**. It is the drug of choice for Absence seizures (as an alternative to Ethosuximide) and Myoclonic seizures. **NEET-PG High-Yield Pearls:** * **Status Epilepticus:** Lorazepam is often preferred over Diazepam due to its longer duration of action in the brain (less redistribution). * **Metabolism:** Temazepam, Oxazepam, and Lorazepam (**T-O-L**) undergo direct glucuronidation (Phase II) and do not form active metabolites, making them safer in elderly patients and those with liver failure. * **Antidote:** Flumazenil is the specific competitive antagonist for BZD overdose.

Question 620: In status epilepticus, what is the drug of choice?

A. Intravenous diazepam (Correct Answer)
B. Intramuscular diazepam
C. Oral clonazepam
D. Intramuscular phenytoin

Explanation: **Explanation:** **Status Epilepticus (SE)** is a medical emergency defined as a continuous seizure lasting more than 5 minutes or recurrent seizures without recovery of consciousness between episodes. The primary goal is rapid termination of seizure activity to prevent neuronal damage. **Why Intravenous (IV) Diazepam is the Correct Choice:** Benzodiazepines are the first-line agents for SE due to their rapid onset of action. They work by enhancing GABA-A mediated inhibitory neurotransmission. **IV Diazepam** (or IV Lorazepam) is preferred because the intravenous route ensures 100% bioavailability and immediate delivery to the brain, crossing the blood-brain barrier rapidly due to its high lipid solubility. **Analysis of Incorrect Options:** * **B. Intramuscular (IM) Diazepam:** Absorption via the IM route is slow, erratic, and unpredictable for diazepam. If IV access is unavailable, **IM Midazolam** is the preferred alternative, not IM diazepam. * **C. Oral Clonazepam:** Oral administration is too slow for an emergency. The patient is often unconscious or actively seizing, posing a significant aspiration risk. * **D. Intramuscular Phenytoin:** Phenytoin is highly alkaline and causes tissue necrosis, pain, and "purple glove syndrome" when given IM. Furthermore, its absorption is delayed. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Initial):** IV Lorazepam is often considered superior to Diazepam in clinical practice due to its longer duration of action in the CNS (less redistribution). However, in many exams, **IV Diazepam** remains the standard answer. * **Next Step:** After stabilizing with a benzodiazepine, **IV Phenytoin or Fosphenytoin** is administered to provide long-term seizure control. * **Refractory SE:** If seizures persist, IV Phenobarbital, Thiopental, or Propofol (general anesthesia) are used.

Practice by Chapter

General Anesthetics

Practice Questions

Local Anesthetics

Practice Questions

Sedative-Hypnotics

Practice Questions

Antiepileptic Drugs

Practice Questions

Antiparkinsonian Drugs

Practice Questions

Opioid Analgesics

Practice Questions

Drugs of Abuse and Addiction

Practice Questions

Psychostimulants

Practice Questions

Hallucinogens

Practice Questions

CNS Stimulants and Cognitive Enhancers

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free